FY2024 Earnings Forecast for BEAM Issued By Leerink Partnrs

Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Equities researchers at Leerink Partnrs boosted their FY2024 earnings per share estimates for Beam Therapeutics in a research note issued on Wednesday, January 22nd. Leerink Partnrs analyst M. Foroohar now forecasts that the company will post earnings of ($4.59) per share for the year, up from their […]

Leave a Reply

Your email address will not be published.

Previous post Red Sox point/counterpoint: Five problems to solve in 2025
Next post Q4 EPS Estimates for TXO Partners Lowered by Analyst